Physician profile
Salman M Malik
NPI 1326132101
$1,231.71
in general payments reported to CMS, 2019-2025
17 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $53.72 · 2021: $218 · 2022: $164 · 2023: $356 · 2024: $46.92 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336 · Education: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $336.13 |
| Education | $232.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $371.99 | 2022-2025 | Watchman Flx, Emblem Mri S-Icd |
| Novo Nordisk INC | $232.00 | 2023 | Ozempic |
| Vifor Pharma, INC. | $200.00 | 2021 | |
| Lantheus Medical Imaging, INC. | $59.80 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $54.09 | 2019-2023 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $50.20 | 2019-2020 | |
| Amarin Pharma, INC. | $35.82 | 2019 | |
| Pfizer INC. | $35.78 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.76 | 2019 | |
| Irhythm Technologies, INC. | $25.13 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.88 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.62 | 2020 | |
| Merck Sharp & Dohme LLC | $21.70 | 2022 | |
| Amryt Pharma Holdings LTD | $18.24 | 2021 | |
| Amgen INC. | $17.11 | 2024 | Repatha |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $16.71 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Abbott Laboratories | $15.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salman Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.